YIH
BIOA

Y-Intercept (HK)’s BioAge Labs BIOA Stock Holding History

Y-Intercept (HK)’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Sell
15,240
-186,097
-92% -$3.36M 0.01% 1401
2026
Q1 		$3.52M Buy
+201,337
New +$3.88M 0.07% 463

Other funds holding BIOA

MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Y-Intercept (HK)'s BIOA Position: Q2 2026 in Review

Y-Intercept (HK) reduced its BioAge Labs (BIOA) stake by 92% in Q2 2026, selling an estimated $3.36M and leaving 15,240 shares worth $374K. The position accounts for 0.01% of the portfolio, ranked #1401.

Y-Intercept (HK) first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.52M in Q1 2026. 11 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Y-Intercept (HK) held 15,240 shares of BioAge Labs worth $374K as of Q2 2026.
  • Y-Intercept (HK) sold 186,097 BioAge Labs shares in Q2 2026, an estimated $3.36M.
  • BioAge Labs made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1401 holding.
  • Y-Intercept (HK) first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
  • Y-Intercept (HK)'s BioAge Labs position peaked at $3.52M in Q1 2026.
  • 11 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.